c-Jun NH2-terminal kinase-interacting protein-3 facilitates phosphorylation and controls localization of amyloid-beta precursor protein

J Neurosci. 2005 Apr 13;25(15):3741-51. doi: 10.1523/JNEUROSCI.0152-05.2005.

Abstract

Abnormal phosphorylation of amyloid-beta precursor protein (APP) is a pathologic feature of Alzheimer's disease. To begin to understand the mechanism of APP phosphorylation, we studied this process in differentiating neurons under normal physiological conditions. We found that c-Jun NH2-terminal kinase (JNK), not cyclin-dependent kinase 5, is required for APP phosphorylation, leading to localized accumulation of phosphorylated APP (pAPP) in neurites. We show that JNK-interacting protein-3 (JIP-3), a JNK scaffolding protein that does not bind APP, selectively increases APP phosphorylation, accumulation of pAPP into processes, and stimulates process extension in both neurons and COS-1 cells. Downregulation of JIP-3 by small interfering RNA impairs neurite extension and reduces the amount of localized pAPP. Finally, whereas stress-activated JNK generates pAPP only in the cell body, concomitant expression of JIP-3 restores pAPP accumulation into neurites. Thus, APP phosphorylation, transport of the generated pAPP into neurites, and neurite extension are interdependent processes regulated by JIP-3/JNK, in a pathway distinct from stress-activated JNK signaling.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adaptor Proteins, Signal Transducing / metabolism
  • Amyloid beta-Protein Precursor / metabolism*
  • Animals
  • Anisomycin / pharmacology
  • Anthracenes / pharmacology
  • Blotting, Western / methods
  • Cell Line
  • Chlorocebus aethiops
  • Enzyme Inhibitors / pharmacology
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / physiology*
  • Growth Inhibitors / pharmacology
  • Humans
  • Immunohistochemistry / methods
  • Immunoprecipitation / methods
  • Mice
  • Mitogen-Activated Protein Kinase 10 / metabolism*
  • Models, Biological
  • Neurites / drug effects
  • Neurites / metabolism
  • Neurons / cytology
  • Neurons / drug effects
  • Neurons / metabolism*
  • Phosphorylation / drug effects
  • Protein Binding / drug effects
  • Purines / pharmacology
  • RNA, Small Interfering / pharmacology
  • Roscovitine
  • Transfection / methods

Substances

  • Adaptor Proteins, Signal Transducing
  • Amyloid beta-Protein Precursor
  • Anthracenes
  • Enzyme Inhibitors
  • Growth Inhibitors
  • Purines
  • RNA, Small Interfering
  • Roscovitine
  • pyrazolanthrone
  • Anisomycin
  • Mitogen-Activated Protein Kinase 10